Specialty & Oncology July 2016
Concerns Regarding Administration of Antineoplastic Therapy in HIV-Positive Patients
There has been some controversy regarding whether or not to initiate HAART simultaneously with chemotherapy.
Treatment Advances in Oncology: Oral Chemotherapy
Several oral chemotherapy agents have been recently approved by the FDA for patients with certain types of cancer.
Continuing Education
$7.95 Per CE Exam or $69 for 12 Lessons
-
• April 2026 • 2.00 Credits
Managing HIV Coinfections and Complications
-
Pain Management • March 2026 • 2.00 Credits
Updated Guidance for Opioid Use in Pain Management
-
Cardiovascular • February 2026 • 2.00 Credits
Managing Modifiable Risk Factors in Chronic Coronary Disease
Copyright © 2000 - 2024 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.